| Donna C Fraysier, MSN, ACNS-BC, APN | |
|
365 Stout Drive, Nicks Hall, Room 160, Johnson City, TN 37614 | |
| (423) 439-4225 | |
| (423) 439-4560 |
| Full Name | Donna C Fraysier |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Adult Health |
| Location | 365 Stout Drive, Johnson City, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487892220 | NPI | - | NPPES |
| Q033568 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SA2200X | Clinical Nurse Specialist - Adult Health | APN0000013716 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Donna C Fraysier, MSN, ACNS-BC, APN Po Box 70403, Johnson City, TN 37614-1703 Ph: (423) 439-4515 | Donna C Fraysier, MSN, ACNS-BC, APN 365 Stout Drive, Nicks Hall, Room 160, Johnson City, TN 37614 Ph: (423) 439-4225 |
News Archive
Johnson & Johnson Pharmaceutical Research & Development, LLC (J&JPRD) announced that health authorities are reviewing scientific data from two clinical trials evaluating an investigational use of the company's Alzheimer's treatment, Reminyl (galantamine hydrobromide), in individuals with mild cognitive impairment.
Babies love to imitate. Ask any parent and they'll report how infants mimic sounds, facial expressions and actions they observe. Now new research from Concordia University, published in the journal Infant Behavior and Development, has found that infants can even differentiate between credible and un-credible sources. Simply put, most babies won't follow along if they have been previously tricked by an adult.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has received an initial dose in a Phase 1/2 clinical study combining MM-121 with Tarceva® (erlotinib) in patients with non-small cell lung cancer (NSCLC). This is the first of multiple trials that Merrimack and sanofi-aventis expect to initiate in 2010 as part of a broad Phase 2 clinical development program for MM-121.
Teva Pharmaceutical Industries Ltd. today announced that several new studies further support the efficacy and safety of the company's innovative central nervous system products.
› Verified 5 days ago
Stephen Lloyd Haile, APN Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 119 Boone Ridge Dr, Suite 201, Johnson City, TN 37615 Phone: 423-282-1480 Fax: 423-928-1353 | |
Lowell E Miller, APN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1203 Old Gray Station Rd, Johnson City, TN 37615 Phone: 423-207-1230 | |
Carol Jones, APN Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 400 N State Of Franklin Rd, Johnson City, TN 37604 Phone: 423-431-6831 | |
Franchesca Maria Shoun, APN Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 310 N State Of Franklin Rd, Suite 101, Johnson City, TN 37604 Phone: 423-929-7393 Fax: 423-929-0872 | |
Laura Renee Parsons, APN Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 119 Boone Ridge Dr, Suite 201, Johnson City, TN 37615 Phone: 423-282-1480 Fax: 423-928-1353 | |
Lisa D Blevins, APN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 403 N State Of Franklin Rd, Johnson City, TN 37604 Phone: 423-431-7111 Fax: 423-431-7092 |